found that chemotherapy-induced IL-34 enhances immunosuppression by tumor-associated macrophages and mediates survival of chemoresistant lung cancer cells, and the patients with lung cancer have a shorter OS in the IL-34 high group compared with that in IL-34 low group, which is opposite to our finding (16). Here, IL34 is linked to lung carcinoma.